BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karimi Askarani H, Iraji A, Rastegari A, Abbas Bukhari SN, Firuzi O, Akbarzadeh T, Saeedi M. Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease. BMC Chem 2020;14:64. [PMID: 33134975 DOI: 10.1186/s13065-020-00715-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Oliyaei N, Moosavi-Nasab M, Tanideh N, Iraji A. Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights. Brain Res Bull 2023;193:11-21. [PMID: 36435362 DOI: 10.1016/j.brainresbull.2022.11.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Elsbaey M, Igarashi Y, Ibrahim MAA, Elattar E. Click-designed vanilloid-triazole conjugates as dual inhibitors of AChE and Aβ aggregation. RSC Adv 2023;13:2871-2883. [DOI: 10.1039/d2ra07539c] [Reference Citation Analysis]
3 Lengerli D, Ibis K, Nural Y, Banoglu E. The 1,2,3-triazole 'all-in-one' ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool. Expert Opin Drug Discov 2022;17:1209-36. [PMID: 36164263 DOI: 10.1080/17460441.2022.2129613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang H, Peng Y, Zhuo L, Wang Y, Zeng G, Wang S, Long L, Li X, Wang Z. Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy. Eur J Med Chem 2022;242:114695. [PMID: 36044812 DOI: 10.1016/j.ejmech.2022.114695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hosseini S, Pourmousavi SA, Mahdavi M, Taslimi P. Synthesis, and in vitro biological evaluations of novel naphthoquinone conjugated to aryl triazole acetamide derivatives as potential anti-Alzheimer agents. Journal of Molecular Structure 2022;1255:132229. [DOI: 10.1016/j.molstruc.2021.132229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Liu T, Chen S, Du J, Xing S, Li R, Li Z. Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease. Eur J Med Chem 2022;227:113973. [PMID: 34752955 DOI: 10.1016/j.ejmech.2021.113973] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Pingaew R, Choomuenwai V, Leechaisit R, Prachayasittikul V, Prachayasittikul S, Prachayasittikul V. 1,2,3-Triazole Scaffold in Recent Medicinal Applications: Synthesis and Anticancer Potentials. HETEROCYCLES 2022;105:147. [DOI: 10.3987/rev-22-sr(r)4] [Reference Citation Analysis]
8 Gupta P, Sharma A. Pharmacological Significance of Triazoles and Tetrazoles in Neurodegenerative Disease: An Overview. N-Heterocycles 2022. [DOI: 10.1007/978-981-19-0832-3_10] [Reference Citation Analysis]
9 Saeedi M, Maleki A, Iraji A, Hariri R, Akbarzadeh T, Edraki N, Firuzi O, Mirfazli SS. Synthesis and bio-evaluation of new multifunctional methylindolinone-1,2,3-triazole hybrids as anti-Alzheimer's agents. Journal of Molecular Structure 2021;1229:129828. [DOI: 10.1016/j.molstruc.2020.129828] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]